Delve Therapeutics Revenue
Biotechnology Research • 
Manhattan, New York, United States • 1-10 Employees
$
Delve Therapeutics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Delve Therapeutics
Michael Flanagan
Chief Technology Officer
Company overview
| Headquarters | 1732 1st Ave, Suite 27466, New York, NY 10128, US |
| Website | |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
Delve Therapeutics Email Formats
Delve Therapeutics uses 1 email format. The most common is {first name} (e.g., john@delvetx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@delvetx.com | 100% |
About Delve Therapeutics
Delve Therapeutics is currently in stealth
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Delve Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Delve Therapeutics has never raised funding before.
Denmark
Portugal
United Arab Emirates
United Kingdom
Frequently asked questions
Delve Therapeutics is located in Manhattan, New York, US.
Delve Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
Delve Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Delve Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.
Delve Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
